BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hupkens BJP, Martens MH, Stoot JH, Berbee M, Melenhorst J, Beets-Tan RG, Beets GL, Breukink SO. Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study. Dis Colon Rectum. 2017;60:1032-1040. [PMID: 28891846 DOI: 10.1097/dcr.0000000000000862] [Cited by in Crossref: 87] [Cited by in F6Publishing: 27] [Article Influence: 17.4] [Reference Citation Analysis]
Number Citing Articles
1 Messick CA, Boutros M. Low anterior resection syndrome: Future directions in treatment and prevention. Seminars in Colon and Rectal Surgery 2021;32:100850. [DOI: 10.1016/j.scrs.2021.100850] [Reference Citation Analysis]
2 Chiloiro G, Meldolesi E, Giraffa M, Capocchiano ND, Barbaro B, Coco C, Corvari B, De Franco P, D'Ugo D, Alfieri S, Manfredi R, Valentini V, Gambacorta MA. Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis. Clin Transl Radiat Oncol 2021;28:1-9. [PMID: 33732909 DOI: 10.1016/j.ctro.2021.02.009] [Reference Citation Analysis]
3 Roeder F, Meldolesi E, Gerum S, Valentini V, Rödel C. Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review. Radiat Oncol 2020;15:262. [PMID: 33172475 DOI: 10.1186/s13014-020-01695-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Anker CJ, Akselrod D, Ades S, Bianchi NA, Lester-coll NH, Cataldo PA. Non-operative Management (NOM) of Rectal Cancer: Literature Review and Translation of Evidence into Practice. Curr Colorectal Cancer Rep 2021;17:23-41. [DOI: 10.1007/s11888-020-00463-2] [Reference Citation Analysis]
5 Annicchiarico A, Martellucci J, Solari S, Scheiterle M, Bergamini C, Prosperi P. Low anterior resection syndrome: can it be prevented? Int J Colorectal Dis 2021. [PMID: 34409501 DOI: 10.1007/s00384-021-04008-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cerdán-santacruz C, Vailati BB, São Julião GP, Habr-gama A, Pérez RO. Watch and wait: Why, to whom and how. Surgical Oncology 2022. [DOI: 10.1016/j.suronc.2022.101774] [Reference Citation Analysis]
7 Munk NE, Bondeven P, Pedersen BG. Diagnostic performance of MRI and endoscopy for assessing complete response in rectal cancer after neoadjuvant chemoradiotherapy: a systematic review of the literature. Acta Radiol 2021;:2841851211065925. [PMID: 34928715 DOI: 10.1177/02841851211065925] [Reference Citation Analysis]
8 Alwers E, Jansen L, Kather J, Amitay E, Bläker H, Kloor M, Tagscherer KE, Roth W, Herpel E, Chang-Claude J, Brenner H, Hoffmeister M. Response to neoadjuvant treatment among rectal cancer patients in a population-based cohort. Int J Colorectal Dis 2021;36:177-85. [PMID: 32949260 DOI: 10.1007/s00384-020-03744-2] [Reference Citation Analysis]
9 Peacock O, Chang GJ. "Watch and Wait" for complete clinical response after neoadjuvant chemoradiotherapy for rectal cancer. Minerva Chir 2019;74:481-95. [PMID: 31580047 DOI: 10.23736/S0026-4733.19.08184-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Glynne-jones R, Bhuva N, Harrison M. Unintended consequences of treating early rectal cancers for complete clinical response with chemoradiotherapy. Colorectal Cancer 2020;9:CRC15. [DOI: 10.2217/crc-2019-0010] [Reference Citation Analysis]
11 Cruz-Fernández M, Achalandabaso-Ochoa A, Gallart-Aragón T, Artacho-Cordón F, Cabrerizo-Fernández MJ, Pacce-Bedetti N, Cantarero-Villanueva I. Quantity and quality of muscle in patients recently diagnosed with colorectal cancer: a comparison with cancer-free controls. Support Care Cancer 2020;28:4745-52. [PMID: 31970516 DOI: 10.1007/s00520-020-05314-2] [Reference Citation Analysis]
12 Kasi A, Abbasi S, Handa S, Al-Rajabi R, Saeed A, Baranda J, Sun W. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3:e2030097. [PMID: 33326026 DOI: 10.1001/jamanetworkopen.2020.30097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
13 Zhang S, Zhang R, Li RZ, Wang QX, Chang H, Ding PR, Li LR, Wu XJ, Chen G, Zeng ZF, Xiao WW, Gao YH. Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer. Cancer Sci 2021;112:3607-15. [PMID: 34146368 DOI: 10.1111/cas.15039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Coffman AR, Tao R, Cohan JN, Huang LC, Pickron TB, Torgeson AM, Lloyd S. Factors associated with the refusal of surgery and the associated impact on survival in patients with rectal cancer using the National Cancer Database. J Gastrointest Oncol 2021;12:1482-97. [PMID: 34532104 DOI: 10.21037/jgo-20-437] [Reference Citation Analysis]
15 Vailati BB, São Julião GP, Habr-gama A, Perez RO. Nonoperative Management of Rectal Cancer. Surgical Oncology Clinics of North America 2022. [DOI: 10.1016/j.soc.2021.11.003] [Reference Citation Analysis]
16 Stijns RCH, de Graaf EJR, Punt CJA, Nagtegaal ID, Nuyttens JJME, van Meerten E, Tanis PJ, de Hingh IHJT, van der Schelling GP, Acherman Y, Leijtens JWA, Bremers AJA, Beets GL, Hoff C, Verhoef C, Marijnen CAM, de Wilt JHW; CARTS Study Group. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study. JAMA Surg. 2019;154:47-54. [PMID: 30304338 DOI: 10.1001/jamasurg.2018.3752] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 22.0] [Reference Citation Analysis]
17 Nocera F, Angehrn F, von Flüe M, Steinemann DC. Optimising functional outcomes in rectal cancer surgery. Langenbecks Arch Surg 2021;406:233-50. [PMID: 32712705 DOI: 10.1007/s00423-020-01937-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
18 Pang X, Wang F, Zhang Q, Li Y, Huang R, Yin X, Fan X. A Pipeline for Predicting the Treatment Response of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Single MRI Modality: Combining Deep Segmentation Network and Radiomics Analysis Based on "Suspicious Region". Front Oncol 2021;11:711747. [PMID: 34422664 DOI: 10.3389/fonc.2021.711747] [Reference Citation Analysis]
19 Aigner F, Gröne J, Kneist W. Organerhalt Rektum: Welche Auswirkungen hat er auf die Lebensqualität? coloproctology 2020;42:324-30. [DOI: 10.1007/s00053-020-00468-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Greer JB, Hawkins AT. Non-operative management of rectal cancer. Semin Colon Rectal Surg 2019;30:79-84. [PMID: 32818013 DOI: 10.1053/j.scrs.2019.04.007] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Lorenzon L, Evrard S, Beets G, Gonzalez-Moreno S, Kovacs T, D'Ugo D, Polom K; CORSiCA Study - EYSAC.1 Study Group. Global variation in the long-term outcomes of ypT0 rectal cancers. Eur J Surg Oncol 2020;46:420-8. [PMID: 31733929 DOI: 10.1016/j.ejso.2019.10.010] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kim JK, Thompson H, Jimenez-Rodriguez RM, Wu F, Sanchez-Vega F, Nash GM, Guillem JG, Paty PB, Wei IH, Pappou EP, Widmar M, Weiser MR, Smith JJ, Garcia-Aguilar J. Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival. Ann Surg Oncol 2021. [PMID: 34601641 DOI: 10.1245/s10434-021-10877-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Rödel C, Diefenhardt M, Fokas E, Gani C. Organerhalt beim Rektumkarzinom durch Radiochemotherapie. coloproctology 2020;42:309-16. [DOI: 10.1007/s00053-020-00477-2] [Reference Citation Analysis]
24 Engineer R, Saklani A, D’souza A, Arya S, Kumar S, Ostwal V, Ramaswamy A, Chopra S, Patil P. Watch and Wait Approach After Neoadjuvant Chemoradiotherapy in Rectal Cancer: Initial Experience in the Indian subcontinent. Indian J Surg Oncol 2021;12:664-70. [DOI: 10.1007/s13193-021-01421-6] [Reference Citation Analysis]
25 Meyer VM, Meuzelaar RR, Schoenaker Y, de Groot JW, de Boer E, Reerink O, de Vos Tot Nederveen Cappel W, Beets GL, van Westreenen HL. Delayed Surgery after Neoadjuvant Treatment for Rectal Cancer Does Not Lead to Impaired Quality of Life, Worry for Cancer, or Regret. Cancers (Basel) 2021;13:742. [PMID: 33670120 DOI: 10.3390/cancers13040742] [Reference Citation Analysis]
26 Lambregts DMJ, Maas M, Boellaard TN, Delli Pizzi A, van der Sande ME, Hupkens BJP, Lahaye MJ, Bakers FCH, Beets GL, Beets-Tan RGH. Long-term imaging characteristics of clinical complete responders during watch-and-wait for rectal cancer-an evaluation of over 1500 MRIs. Eur Radiol 2020;30:272-80. [PMID: 31428827 DOI: 10.1007/s00330-019-06396-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
27 Neibart SS, Manne SL, Jabbour SK. Quality of Life After Radiotherapy for Rectal and Anal Cancer. Curr Colorectal Cancer Rep 2020;16:1-10. [PMID: 32632345 DOI: 10.1007/s11888-019-00448-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Smith JJ, Paty PB, Garcia-Aguilar J. Watch and Wait in Rectal Cancer or More Wait and See? JAMA Surg 2020;155:657-8. [PMID: 32347912 DOI: 10.1001/jamasurg.2020.0226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
29 Kupsch J, Kuhn M, Matzel KE, Zimmer J, Radulova-Mauersberger O, Sims A, Witzigmann H, Stelzner S. To what extent is the low anterior resection syndrome (LARS) associated with quality of life as measured using the EORTC C30 and CR38 quality of life questionnaires? Int J Colorectal Dis. 2019;34:747-762. [PMID: 30721417 DOI: 10.1007/s00384-019-03249-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
30 López-Campos F, Martín-Martín M, Fornell-Pérez R, García-Pérez JC, Die-Trill J, Fuentes-Mateos R, López-Durán S, Domínguez-Rullán J, Ferreiro R, Riquelme-Oliveira A, Hervás-Morón A, Couñago F. Watch and wait approach in rectal cancer: Current controversies and future directions. World J Gastroenterol 2020; 26(29): 4218-4239 [PMID: 32848330 DOI: 10.3748/wjg.v26.i29.4218] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
31 Park SH, Cho SH, Choi SH, Jang JK, Kim MJ, Kim SH, Lim JS, Moon SK, Park JH, Seo N; Korean Society of Abdominal Radiology Study Group for Rectal Cancer. MRI Assessment of Complete Response to Preoperative Chemoradiation Therapy for Rectal Cancer: 2020 Guide for Practice from the Korean Society of Abdominal Radiology. Korean J Radiol 2020;21:812-28. [PMID: 32524782 DOI: 10.3348/kjr.2020.0483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Wang QX, Zhang S, Xiao WW, Zhou CJ, Chang H, Zeng ZF, Cai PQ, Lu ZH, Chen G, Ding PR, Pan ZZ, Wu XJ, Gao YH. High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer. Radiat Oncol 2022;17:98. [PMID: 35585551 DOI: 10.1186/s13014-022-02066-7] [Reference Citation Analysis]
33 Quezada-Diaz FF, Elfeki H, Emmertsen KJ, Pappou EP, Jimenez-Rodriguez R, Patil S, Laurberg S, Garcia-Aguilar J. Comparative analysis of the Memorial Sloan Kettering Bowel Function Instrument and the Low Anterior Resection Syndrome Questionnaire for assessment of bowel dysfunction in rectal cancer patients after low anterior resection. Colorectal Dis 2021;23:451-60. [PMID: 33405307 DOI: 10.1111/codi.15515] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Christensen P, Im Baeten C, Espín-Basany E, Martellucci J, Nugent KP, Zerbib F, Pellino G, Rosen H; MANUEL Project Working Group. Management guidelines for low anterior resection syndrome - the MANUEL project. Colorectal Dis 2021;23:461-75. [PMID: 33411977 DOI: 10.1111/codi.15517] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
35 Hunt SR. Watch-and-Wait as a Strategy for Appropriately Selected Rectal Cancer Patients. J Am Coll Surg 2020;231:692-4. [PMID: 33243398 DOI: 10.1016/j.jamcollsurg.2020.10.006] [Reference Citation Analysis]
36 Quezada-diaz FF, Smith JJ. Neoadjuvant Therapy for Rectal Cancer. Surgical Oncology Clinics of North America 2022. [DOI: 10.1016/j.soc.2021.11.008] [Reference Citation Analysis]
37 On J, Aly EH. 'Watch and wait' in rectal cancer: summary of the current evidence. Int J Colorectal Dis 2018;33:1159-68. [PMID: 29978363 DOI: 10.1007/s00384-018-3116-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
38 Rink AD. Funktionelle Folgen der intensivierten Radiochemotherapie zur organerhaltenden Behandlung des Rektumkarzinoms. coloproctology 2022;44:49-51. [DOI: 10.1007/s00053-021-00579-5] [Reference Citation Analysis]
39 Eid Y, Bouvier V, Dejardin O, Menahem B, Chaillot F, Chene Y, Dutheil JJ, Juul T, Morello R, Alves A. 'French LARS score': validation of the French version of the low anterior resection syndrome (LARS) score for measuring bowel dysfunction after sphincter-preserving surgery among rectal cancer patients: a study protocol. BMJ Open 2020;10:e034251. [PMID: 32152168 DOI: 10.1136/bmjopen-2019-034251] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Hammarström K, Imam I, Mezheyeuski A, Ekström J, Sjöblom T, Glimelius B. A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer. Cancers (Basel) 2020;13:E16. [PMID: 33375133 DOI: 10.3390/cancers13010016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
41 Bujko K, Glynne-Jones R, Papamichael D, Rutten HJT. Optimal management of localized rectal cancer in older patients. J Geriatr Oncol 2018;9:696-704. [PMID: 30150020 DOI: 10.1016/j.jgo.2018.08.001] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
42 Miura T, Sakamoto Y, Morohashi H, Suto A, Kubota S, Ichisawa A, Kuwata D, Yamada T, Tamba H, Matsumoto S, Hakamada K. Robotic surgery contributes to the preservation of bowel and urinary function after total mesorectal excision: comparisons with transanal and conventional laparoscopic surgery. BMC Surg 2022;22:147. [PMID: 35449005 DOI: 10.1186/s12893-022-01596-x] [Reference Citation Analysis]
43 Quezada-Diaz F, Jimenez-Rodriguez RM, Pappou EP, Joshua Smith J, Patil S, Wei I, Guillem JG, Paty PB, Nash GM, Weiser MR, Garcia-Aguilar J. Effect of Neoadjuvant Systemic Chemotherapy With or Without Chemoradiation on Bowel Function in Rectal Cancer Patients Treated With Total Mesorectal Excision.J Gastrointest Surg. 2019;23:800-807. [PMID: 30350191 DOI: 10.1007/s11605-018-4003-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
44 Dijkstra EA, Hospers GAP, Meershoek-Klein Kranenbarg E, Fleer J, Roodvoets AGH, Bahadoer RR, Guren MG, Tjalma JJJ, Putter H, Crolla RMPH, Hendriks MP, Capdevila J, Radu C, van de Velde CJH, Nilsson PJ, Glimelius B, van Etten B, Marijnen CAM; collaborative investigators. Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - the RAPIDO trial. Radiother Oncol 2022:S0167-8140(22)00194-3. [PMID: 35447283 DOI: 10.1016/j.radonc.2022.04.013] [Reference Citation Analysis]
45 Custers PA, Hupkens BJP, Grotenhuis BA, Kuhlmann KFD, Breukink SO, Beets GL, Melenhorst J, Beets‐tan RGH, Buijsen J, Festen S, de Graaf EJR, Haak HE, Hilling DE, Hoff C, Intven M, Komen N, Kusters M, van Leerdam ME, Peeters KCMJ, Peters FP, Pronk A, van der Sande ME, Schreurs WH, Sonneveld DJA, Talsma AK, Tuynman JB, Valkenburg‐van Iersel LBJ, Vermaas M, de Vos‐geelen J, van Westreenen HL, de Wilt JHW, Zimmerman DDE; the Dutch Watch‐and‐Wait Consortium (collaborators). Selected stage IV rectal cancer patients managed by the watch‐and‐wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery? Colorectal Disease. [DOI: 10.1111/codi.16034] [Reference Citation Analysis]
46 Quezada-Diaz FF, Smith JJ. Nonoperative Management for Rectal Cancer. Hematol Oncol Clin North Am 2022:S0889-8588(22)00014-4. [PMID: 35562257 DOI: 10.1016/j.hoc.2022.03.003] [Reference Citation Analysis]
47 Fokas E, Appelt A, Glynne-Jones R, Beets G, Perez R, Garcia-Aguilar J, Rullier E, Joshua Smith J, Marijnen C, Peters FP, van der Valk M, Beets-Tan R, Myint AS, Gerard JP, Bach SP, Ghadimi M, Hofheinz RD, Bujko K, Gani C, Haustermans K, Minsky BD, Ludmir E, West NP, Gambacorta MA, Valentini V, Buyse M, Renehan AG, Gilbert A, Sebag-Montefiore D, Rödel C. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nat Rev Clin Oncol 2021. [PMID: 34349247 DOI: 10.1038/s41571-021-00538-5] [Reference Citation Analysis]
48 Nacion AJD, Park YY, Yang SY, Kim NK. Critical and Challenging Issues in the Surgical Management of Low-Lying Rectal Cancer. Yonsei Med J 2018;59:703-16. [PMID: 29978607 DOI: 10.3349/ymj.2018.59.6.703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Gani C, Kirschniak A, Zips D. Watchful Waiting after Radiochemotherapy in Rectal Cancer: When Is It Feasible? Visc Med 2019;35:119-23. [PMID: 31192245 DOI: 10.1159/000499167] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
50 do Canto LM, Larsen SJ, Catin Kupper BE, Begnami MDFS, Scapulatempo-Neto C, Petersen AH, Aagaard MM, Baumbach J, Aguiar S Jr, Rogatto SR. Increased Levels of Genomic Instability and Mutations in Homologous Recombination Genes in Locally Advanced Rectal Carcinomas. Front Oncol 2019;9:395. [PMID: 31192117 DOI: 10.3389/fonc.2019.00395] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
51 Anker CJ, Lester-coll NH, Akselrod D, Cataldo PA, Ades S. The Potential for Overtreatment With Total Neoadjuvant Therapy (TNT): Consider One Local Therapy Instead. Clinical Colorectal Cancer 2021. [DOI: 10.1016/j.clcc.2021.11.001] [Reference Citation Analysis]
52 Felder SI, Feuerlein S, Parsee A, Imanirad I, Sanchez J, Dessureault S, Kim R, Hoffe S, Frakes J, Costello J. Endoscopic and MRI response evaluation following neoadjuvant treatment for rectal cancer: a pictorial review with matched MRI, endoscopic, and pathologic examples. Abdom Radiol (NY) 2021;46:1783-804. [PMID: 33111189 DOI: 10.1007/s00261-020-02827-6] [Reference Citation Analysis]
53 Fernandez LM, São Julião GP, Vailati BB, Habr-Gama A, Perez RO. Nonoperative Management for T2 Low Rectal Cancer: A Western Approach. Clin Colon Rectal Surg 2020;33:366-71. [PMID: 33162841 DOI: 10.1055/s-0040-1714241] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Garfinkle R, Boutros M. Low Anterior Resection Syndrome: Predisposing Factors and Treatment. Surg Oncol 2021;:101691. [PMID: 34863592 DOI: 10.1016/j.suronc.2021.101691] [Reference Citation Analysis]